Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Campath in Nonmyeloablative Transplantation
NCT00038844Phase 2Completed
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Jun 2001
- Primary completion
- Dec 2007
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of alemtuzumab in lymphoma, leukemia, sponsored by University of Texas MD Anderson Cancer Center. Started Jun 2001; status: completed.
02
Drugs
alemtuzumab
03
Conditions
lymphomaleukemia
Beyond the preview
Go deeper on NCT00038844.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00038844.